BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16258068)

  • 1. The ETV6-NTRK3 chimeric tyrosine kinase suppresses TGF-beta signaling by inactivating the TGF-beta type II receptor.
    Jin W; Kim BC; Tognon C; Lee HJ; Patel S; Lannon CL; Maris JM; Triche TJ; Sorensen PH; Kim SJ
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16239-44. PubMed ID: 16258068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TrkC binds to the type II TGF-beta receptor to suppress TGF-beta signaling.
    Jin W; Yun C; Kwak MK; Kim TA; Kim SJ
    Oncogene; 2007 Dec; 26(55):7684-91. PubMed ID: 17546043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
    Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
    J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A highly conserved NTRK3 C-terminal sequence in the ETV6-NTRK3 oncoprotein binds the phosphotyrosine binding domain of insulin receptor substrate-1: an essential interaction for transformation.
    Lannon CL; Martin MJ; Tognon CE; Jin W; Kim SJ; Sorensen PH
    J Biol Chem; 2004 Feb; 279(8):6225-34. PubMed ID: 14668342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells.
    Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K
    Br J Cancer; 2010 Mar; 102(5):844-51. PubMed ID: 20145621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation.
    Song K; Wang H; Krebs TL; Danielpour D
    EMBO J; 2006 Jan; 25(1):58-69. PubMed ID: 16362038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoids recruit Tgfbr3 and Smad1 to shift transforming growth factor-β signaling from the Tgfbr1/Smad2/3 axis to the Acvrl1/Smad1 axis in lung fibroblasts.
    Schwartze JT; Becker S; Sakkas E; Wujak ŁA; Niess G; Usemann J; Reichenberger F; Herold S; Vadász I; Mayer K; Seeger W; Morty RE
    J Biol Chem; 2014 Feb; 289(6):3262-75. PubMed ID: 24347165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta (TGF-beta) signaling is regulated by electrical activity in skeletal muscle cells. TGF-beta type I receptor is transcriptionally regulated by myotube excitability.
    Ugarte G; Brandan E
    J Biol Chem; 2006 Jul; 281(27):18473-81. PubMed ID: 16682418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Betaglycan inhibits TGF-beta signaling by preventing type I-type II receptor complex formation. Glycosaminoglycan modifications alter betaglycan function.
    Eickelberg O; Centrella M; Reiss M; Kashgarian M; Wells RG
    J Biol Chem; 2002 Jan; 277(1):823-9. PubMed ID: 11668175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
    Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis.
    Petersen M; Thorikay M; Deckers M; van Dinther M; Grygielko ET; Gellibert F; de Gouville AC; Huet S; ten Dijke P; Laping NJ
    Kidney Int; 2008 Mar; 73(6):705-15. PubMed ID: 18075500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.
    Heldin NE; Bergström D; Hermansson A; Bergenstråhle A; Nakao A; Westermark B; ten Dijke P
    Mol Cell Endocrinol; 1999 Jul; 153(1-2):79-90. PubMed ID: 10459856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the role of homomeric and heteromeric receptor interactions in TGF-beta signaling using small molecule dimerizers.
    Stockwell BR; Schreiber SL
    Curr Biol; 1998 Jun; 8(13):761-70. PubMed ID: 9651680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smad regulation in TGF-beta signal transduction.
    Moustakas A; Souchelnytskyi S; Heldin CH
    J Cell Sci; 2001 Dec; 114(Pt 24):4359-69. PubMed ID: 11792802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
    Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
    Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C18 ORF1, a novel negative regulator of transforming growth factor-β signaling.
    Nakano N; Maeyama K; Sakata N; Itoh F; Akatsu R; Nakata M; Katsu Y; Ikeno S; Togawa Y; Vo Nguyen TT; Watanabe Y; Kato M; Itoh S
    J Biol Chem; 2014 May; 289(18):12680-92. PubMed ID: 24627487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor beta signaling through interaction with CREB-binding protein/p300.
    Mori N; Morishita M; Tsukazaki T; Giam CZ; Kumatori A; Tanaka Y; Yamamoto N
    Blood; 2001 Apr; 97(7):2137-44. PubMed ID: 11264182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta stimulates intestinal epithelial focal adhesion kinase synthesis via Smad- and p38-dependent mechanisms.
    Walsh MF; Ampasala DR; Hatfield J; Vander Heide R; Suer S; Rishi AK; Basson MD
    Am J Pathol; 2008 Aug; 173(2):385-99. PubMed ID: 18583311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heteromeric and homomeric transforming growth factor-beta receptors show distinct signaling and endocytic responses in epithelial cells.
    Doré JJ; Edens M; Garamszegi N; Leof EB
    J Biol Chem; 1998 Nov; 273(48):31770-7. PubMed ID: 9822641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.